Sign in
4

Changes in Ownership

Black Diamond Therapeutics, Inc. Filed Acc 0001415889-22-012797

Director acquired 8,424 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Velleca Mark A. · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-12-16 Grant or award : show line 1 in the form +8,424 $1.50 $12,636 21,157 D
Loading xslF345X03/form4-12202022_021242.xml…